Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency - Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency
There are no views created for this resource yet.
Additional Information
Created | July 29, 2021 |
---|---|
Format | HTML |